CompletedNot Applicable

Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean

United States117 participantsStarted 2015-11

Plain-language summary

The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cesarean * Presence of post-operative ISP, VAS \>5/10 * American Society of Anesthesiologists Class 1 - 3. * No allergy to lidocaine Exclusion Criteria: * American Society of Anesthesiologists Class 4 or 5. * Allergy to lidocaine * Nasal pathology (e.g., deviated septum) * Patients who receive sedatives during cesarean * Bleeding diathesis * Any patient who the PI feels will be unable to comply with all protocol related procedures * Shoulder pain prior to cesarean

What they're measuring

Reduction of shoulder pain measured using Verbal Analog pain Scale (VAS)

Timeframe: 90 Minutes

Trial details

NCT IDNCT02670057

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-12

View on ClinicalTrials.gov More Ipsilateral Shoulder Pain trials